© 2026 Sparkline Capital LP. All rights reserved.

For informational purposes only. Not investment advice or a recommendation of any security or fund. Past performance is not indicative of future results.

Terms of Service | Privacy Policy | Disclosures | Methodology |

ANALYTICS
AnalysisScreenerGroups

Selection

Selected (1/4)

FACDX

Seeded with the selected fund at 100%

Benchmark

Pick one fund or composite — returns and exposures render in excess of it

Peer Universe

Reference set for percentile ranks and factor bars

Equity Funds · 5,640 total

ANALYTICS
AnalysisScreenerGroups

FACDX

Sector

Fidelity Advisor Health Care Fund

Expense Ratio
0.96%
AUM
$3.4B
Inception
8/30/1996
1Y Return
+24.4%84th %ilevs 5,640 asset-class peers
·

The fund normally invests primarily in common stocks. It invests at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

Time Series
–

Performance

NameCumulative ReturnAnn. ReturnAnn. VolSharpeMax DD
FACDX
Fidelity Advisor Health Care Fund
24.4%24.4%18.2%1.13-13.4%
ⓘ Methodology

ETF performance based on market prices. Drag on chart to select period. Sharpe Ratio uses the one-month T-bill as the risk-free rate. From 10/7/2025 to 10/7/2026.

Trailing Returns

Name
YTD1D5D1M3M6M1Y2Y3Y5YMAX
FACDX
Fidelity Advisor Health Care Fund
15.1%-0.1%-2.6%-2.2%1.9%21.1%24.4%11.1%13.9%5.0%10.9%
ⓘ Methodology

ETF performance based on market prices. Returns for periods greater than one year are annualized. As of 10/7/2026.

Annual Returns

Name
199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025YTD
FACDX
Fidelity Advisor Health Care Fund
10.3%*22.6%39.8%1.8%36.2%-15.1%-18.2%15.6%8.0%16.3%6.1%9.5%-33.0%31.8%17.6%7.3%19.6%55.8%32.4%6.0%-10.3%24.1%7.2%27.9%21.1%11.3%-13.1%3.8%4.0%14.2%15.1%
ⓘ Methodology

* partial year — the series ran for only part of it (its first year, or the year it closed); the figure is the return over the part it did run. ETF performance based on market prices. As of 10/7/2026.

Correlation Matrix

Benchmark

Select a second series, or to correlate with the seven research factors.

Factor Regression

Name
Ann. αβ MKTβ SMBβ HMLβ RMWβ CMAβ UMDβ iHMLR²Obs
FACDXUS
Fidelity Advisor Health Care Fund
19.2%0.40**0.61**-0.51**-0.180.48**-0.03-0.050.37226
ⓘ Methodology

ETF performance based on market prices. US factor set. Daily OLS of excess return (fund − T-bill) on factor spread returns over the selected date range, intersected with each series' history. Bold with * |t| ≥ 1.96, ** |t| ≥ 2.58. Cell shading tracks each loading's t-stat. Betas are returns-based — compare with the holdings-based factor scores below. Factor returns are long-short spread returns (© Ken French, Dartmouth). From 10/7/2025 to 8/31/2026.

SnapshotAs ofvsⓘ

Fund ProfileSector

Fund Documents(opens the fund company’s site in a new tab)
Family
Registrant
Type
Mutual Fund
Asset Class
Equity
Region
Equity Size & Style
Peer Group Benchmark
Peer Group
Sector - Healthcare (69 peers)
1Y Peer Percentile
82
3Y Peer Percentile
69
Expense Ratio
0.96%
5Y Tax Drag
1.39%/yr
AUM
$3.4B
3Y Flow
-46.1%
Yield
0.00%
Inception
8/30/1996
Holdings (Reported)
154
Turnover
74%
Equity
97%
Derivatives
0%
Net Equity Exposure
100%
Strategy Summary

The fund normally invests primarily in common stocks. It invests at least 80% of assets in securities of companies principally engaged in the design, manufacture, or sale of products or services used for or in connection with health care or medicine. The fund invests in domestic and foreign issuers. It uses fundamental analysis of factors such as each issuer's financial condition and industry position, as well as market and economic conditions, to select investments.

ⓘ Methodology

Expense ratio and its components from the fund's prospectus fee table; tax drag from its after-tax return table. Turnover from the SEC annual report (9/22/2026). Yield as of 10/6/2026, AUM 9/30/2026. Holdings, asset class, style, peer group and exposures as of 7/31/2026. Strategy summary from the fund's prospectus. Summary may be from an older prospectus.

Equity Size & Style Map

LargeMidSmall
8%
24%
14%
5%
-
17%
-
3%
29%
Large
ValueCoreGrowth
Size
Large
46%
Mid
23%
Small
31%
Style
Value
13%
Core
27%
Growth
60%
ⓘ Methodology

Equity size and style definitions. Size: each holding is scored against its own market's size curve — Large above $61.7B in the US and $21.4B elsewhere, Small below $10.8B worldwide — and a fund sits at the weighted average of its holdings. Style: each holding's Traditional Value score is ranked against stocks of the same region and size, and a fund sits at the weighted average of those ranks. Both are relative measures — where a holding stands among comparable stocks, not an absolute threshold. The dollar lines are recomputed from total market capitalisation each time the data is refreshed; the shares of the market they mark are what stay fixed. Cell shading and percentages: share of classified holdings weight per box. The grid and the dot are built from one set of per-holding scores — the dot is their weighted average — so they describe the same book at two levels of detail. The Size and Style bars are the grid's row and column totals. Holdings as of 7/31/2026. Stock-level data as of 8/31/2026.

Composite FactorsRef: Equity Funds

Intangible Value50.5
Traditional Value14.7
Small-Cap67.0
Quality12.4
Momentum85.3
ⓘ Methodology

Hover or click for factor definitions. Weighted average of underlying company-level values with weights equal to position size. Ranked within the clean equity fund universe, one entry per fund series (lowest: 0, highest: 100; the middle of the range is denser than the ends). Blue dots mark the fund; the shaded band spans the Equity Funds class 25th–75th percentile of scores, notched at the median. Holdings as of 7/31/2026. Stock-level data as of 8/31/2026.

Factor DetailsRef: Equity Funds

Valuation
Book-to-Price (NTM)19.3
Sales-to-Price (NTM)28.8
Earnings-to-Price (NTM)1.3
Innovation/IP
R&D / Mkt Cap2.7
Patents / Mkt Cap0.49
Brand
Sales & Marketing / Mkt Cap0.96
Trademarks / Mkt Cap0.08
Human Capital
PhD Employees / Mkt Cap14.6
Top University Alumni / Mkt Cap14.7
Politics
Lobbying Spend / Mkt Cap18.3
AI
AI Employees / Mkt Cap0.64
ⓘ Methodology

Hover or click for factor definitions. Weighted average of underlying company-level values with weights equal to position size. Solid blue dots mark the fund's position within the clean equity fund universe (5th–95th percentile scale); the shaded band spans the fund's broad class (Equity Funds) 25th–75th percentile, notched at the median. Holdings as of 7/31/2026. Stock-level data as of 8/31/2026. Expense ratio, yield, and turnover as of 10/6/2026. AUM as of 9/30/2026.

Country Exposure

Level
89.0%
89.0%
10.9%
2.5%
2.2%
2.0%
1.3%
1.0%
Other2.0%
ⓘ Methodology

Shares are percentages of the holdings that carry a country, not portfolio weights. Holdings as of 7/31/2026. Stock-level data as of 8/31/2026.

Sector Exposure

Level
100.0%
ⓘ Methodology

Shares are percentages of the fund's classified holdings — every position we can identify, with cash and unidentified positions excluded — not portfolio weights. Holdings as of 7/31/2026. Stock-level data as of 8/31/2026.

Thematic Exposure

AI Composition

Infrastructure1.9%
Early Adopter32.5%
Laggard65.7%

Magnificent 7

Magnificent 70.0%
Non-Magnificent 7100.0%

Old vs New Economy

Old Economy9.1%
New Economy90.9%

Globalization

Multinational53.0%
Exporter0.3%
Importer10.7%
Domestic35.9%

China Exposure

China/HK Domiciled0.0%
Revenue & Operations1.8%
Operations Only27.9%
Revenue Only2.2%
No Material Exposure68.1%

Company Size

Mega (>$500B)11.8%
Large ($70–500B)26.5%
Mid ($10–70B)31.7%
Small ($1–10B)28.8%
Micro (<$1B)1.2%
ⓘ Methodology

Shares are percentages of the fund's classified equity book, renormalized so each split sums to 100% (the equity book is 97% of net assets) — they are not portfolio weights. China exposure: domiciled = incorporated in China or Hong Kong, falling back to the filing's country for holdings outside the stock model. Among the rest, revenue = ≥15% of revenue derived from China; operations = ≥3% of LinkedIn-tracked workforce in China, or ≥2 identified Chinese suppliers making up ≥12% of those identified. China revenue is estimated where segment reporting is absent. Company size bands by holding market cap: Mega >$500B, Large $70–500B, Mid $10–70B, Small $1–10B, Micro <$1B. Old vs New Economy partitions Sparkline's 48 industries: New = technology, internet platforms and entertainment, e-commerce, payments, pharma/biotech/medtech, and renewable energy; Old = everything else. Shares are of classified holdings and sum to 100%. China shares are of total equity weight. Size shares are of scored holdings weight. Holdings as of 7/31/2026. Stock-level data as of 8/31/2026.

Holdings

See more rows — create a free account▾

154 positions (top 10 shown, create for full holdings)

#NameTickerWeight %SectorIndustryCountry
1ELI LILLY andLLY
7.66
HealthcarePharmaceuticalsUSA
2DanaherDHR
6.75
HealthcareMedical TechnologyUSA
3Thermo Fisher ScientificTMO
6.31
HealthcareBiotech & Life SciUSA
4Unitedhealth GroupUNH
4.17
HealthcareInsurers & ProvidersUSA
5JOHNSON and JOHNSONJNJ
3.78
HealthcarePharmaceuticalsUSA
6AbbvieABBV
3.62
HealthcareBiotech & Life SciUSA
7Fidelity Revere Street Trust-
2.54
--USA
8ArgenxARGX
2.09
HealthcareBiotech & Life SciNLD
9MERCK andMRK
2.09
HealthcarePharmaceuticalsUSA
10West Pharmaceutical SVCSWST
2.06
HealthcareMedical TechnologyUSA
ⓘ Methodology

Sector, country and factor detail need a security match; the share of weight that matched is a member figure, so the rows without one appear here with those columns blank. Holdings as of 7/31/2026. Stock-level data as of 8/31/2026.

ConcentrationRef: Equity Funds

Total Holdings154
Effective Holdings39.5
Top 10 Weight41.1%
Max Position7.7%
Top Sector (of Net Assets)97%
Top Country (of Net Assets)88%
ⓘ Methodology

Hover or click for definitions. Solid blue dots mark the fund: percentage rows on a 0–100% scale, holdings counts log-scaled across the clean-universe 5th–95th percentile range. The shaded band spans the fund's broad class (Equity Funds) 25th–75th percentile, notched at the median. Holdings as of 7/31/2026.

Benchmark DifferentiationRef: Equity Funds

vs SPYBroad Benchmark
Active Share94.2%
Tracking Error16.1%
Benchmark Correlation0.41
vs IWPStyle Benchmark
Active Share94.7%
Tracking Error18.5%
Benchmark Correlation0.45
ⓘ Methodology

One sub-card per benchmark: the market primary, then the style secondary — the gap between them is the style sleeve itself. Both anchors are Sparkline-inferred (market from asset class and region, style from the holdings size-and-style map), not the fund's official prospectus benchmark. Solid blue dot marks the fund; the shaded band spans the reference set's 25th–75th percentile, notched at the median (band follows the Peer Universe selector). Active Share compares the fund's book with the benchmark's, share for share; Tracking Error is the annualized daily deviation over the trailing two years (ruler runs to just past the universe's 95th percentile, or past the fund's own figure where that is larger); Benchmark Correlation is the plain daily correlation over the trailing year. Hover the labels for full definitions.

Peer Group Rank

See All Peer Groups
Metric
FACDX
Fidelity Advisor Health Care Fund
Peer Group
69 funds
Peer Asset Class
5,640 funds
YTD Return
15.06%8.24%7811.63%70
1Y Return
24.39%17.69%8214.44%84
3Y Return (Ann.)
13.90%11.69%6918.50%24
5Y Return (Ann.)
5.02%4.91%518.64%23
Expense Ratiohigher = cheaper
0.96%0.65%260.74%30
ⓘ Methodology

Sparkline's own holdings-based peer taxonomy (142 share classes across 69 funds). One share class shown per fund — the exchange-listed class where the SEC series has one, else its longest-history class; percentile ranks and medians are computed against the same deduped set. Quartile chips fill the layer the fund's rank falls in (top layer = best quartile). Funds without a full return history rank only on the horizons they cover.

Similar Funds

See more rows — create a free account▾

Nearest funds across the whole universe, by holdings and behavior — the peer taxonomy is ignored, so matches can come from any category.

Top Similarity90
Top Overlap
Top Active Tilt
Top Factor Match
Top Return Corr
Top FF Match
FundPeer Group
1FSPHX
Select Health Care Portfolio
Sector - Healthcare
Sector - Healthcare
90-----
2JEHSX
Health Sciences Trust
Sector - Healthcare
Sector - Healthcare
60-----
3FMED
Fidelity Disruptive Medicine ETF
Sector - Healthcare
Sector - Healthcare
56-----
4PRHSX
T. Rowe Price Health Sciences Fund, Inc.
Sector - Healthcare
Sector - Healthcare
56-----
5LHCAX
Lord Abbett Health Care Fund
Sector - Healthcare
Sector - Healthcare
56-----
6PHLAX
PGIM Jennison Health Sciences Fund
Sector - Healthcare
Sector - Healthcare
56-----
7JAGLX
Janus Henderson Global Life Sciences Fund
Sector - Healthcare
Sector - Healthcare
55-----
8BHCFX
Baron Health Care Fund
Sector - Healthcare
Sector - Healthcare
55-----
9GGHCX
Invesco Health Care Fund
Sector - Healthcare
Sector - Healthcare
49-----
10IBBQ
Invesco Nasdaq Biotechnology ETF
Sector - Biotech
Sector - Biotech
49-----

The method columns are members-only — create a free account to see these figures.

ⓘ Methodology

Rows are the consensus top matches (a fund must place in at least two methods' top 250 to qualify, and matches missing more than one of this fund's own methods are not ranked — a row scored on fewer methods is a noisier estimate, not a better match). Click a method column to see that method's own top matches across the whole universe instead. Gray (N) beside each method's metric is that fund's rank in the whole universe on that method. Similarity is a percentile among match-grade fund pairs, 0–100 — 87 means the pair is closer than 87% of the strongest matches in the universe, averaged across the methods — so it compares across funds: index clones tie at the top with thousands of other clone pairs, so scores top out in the high 80s to 90s, while a one-of-a-kind fund's best match can score in the 30s. Rows are ordered by the Consensus Rank — the geometric mean of those universe ranks, shown in each cell's tooltip — and the score is held down the list to the level of the closest match above it, so equal scores mean equally close and the number reads as a floor. A dash means that method has no figure for the pair at all (one of them lacks the holdings or return history it needs). Hover a column header for each method's definition. The “Top…” strips above compare against every fund's own top match across the whole universe (they deliberately don't follow the Peer Universe selector); Top Similarity is simply the best match's score, with no reference band; the Holdings and Active Tilt strips carry no reference band because computing every fund's best book overlap would require a full holdings scan per fund — the dot stands alone on its natural 0–100% scale. One share class shown per fund, and a fund's own sister share classes are excluded from its Top-match strips. Holdings as of 7/31/2026. Consensus Rank is the geometric mean of the match's universe-wide rank across the methods (#1.0 = top match on every one). Holdings Overlap = common-holdings weight (sum of the minimum weight across shared positions, long only). Active Tilt Overlap = the same statistic on active weights (holdings minus the fund's own default benchmark, floored at 0), which strips the benchmark ballast that dominates raw overlap. Factor Similarity = 100 − a signature-weighted RMS gap across the composite factor scores (0–100 ranks within the clean equity fund universe), each axis weighted by how far this fund sits from the universe median of 50. Return Correlation = correlation of market-hedged daily returns over the trailing two years (CAPM residuals), so only market-beta co-movement is removed; requires ~18 months of daily history (378 of the window's 504 trading days). Fama-French Similarity = 1/(1+d), where d is the Euclidean distance between factor betas (market, size, value, profitability, investment, momentum, intangible value) from up to three years of daily returns (min 378 daily observations and regression R² of at least 0.25); 1.00 = identical loadings.